April 14, 2025

Adult Swim Lessons, Pediatric Lives Saved

“If we can get everybody to learn how to swim, just that little bit, it would save so many lives."

KFF Health News

April 14, 2025

Inebilizumab Effective for Myasthenia Gravis

CD19+ B-cell-depleting therapy shows significant improvement in function and disease severity in phase III trial of autoimmune neuromuscular disorder.

Conexiant

April 14, 2025

Early RNAi Therapeutic Treatment May Improve Survival in hATTR-PN

"In a disease characterized by unrelenting decline, the results depict the long-term clinical stability afforded by TTR reduction and the long-term safety of patisiran treatment."

Conexiant

April 14, 2025

1 in 5 Patients Face Stroke Within Decade After TIA

Meta-analysis of 171,000+ patients shows persistent long-term stroke risk following TIA, with half of recurrent events occurring after the first year.

Conexiant

April 11, 2025

New Self-Injection Option for gMG, CIDP

A prefilled syringe version of VYVGART Hytrulo, which enables adult patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathy to self-administer treatment in as little as 20 to 30 seconds, has been approved by the FDA.

Conexiant

April 10, 2025

Microplastics Linked to Brain Disability Spike

Higher rates of cognitive, mobility, and self-care disabilities found in coastal counties with elevated marine microplastic levels.

Conexiant

April 10, 2025

FDA to Pilot Animal-Free Models

"This initiative marks a paradigm shift in drug evaluation and holds promise to accelerate cures and meaningful treatments for Americans while reducing animal use."

Reuters

April 10, 2025

Model Predicts Pediatric Seizure Recurrence

Elevated risk scores are significantly associated with an increased likelihood of seizure recurrence, according to a recent study on pediatric epilepsy.

Conexiant

April 09, 2025

Buprenorphine Data Reveal Prescribing Pivot

The rise in extended-release buprenorphine patients signals increasing access and a willingness to adopt this treatment option, researchers noted.

Conexiant